People
Jacobs selected by Sanofi to deliver new insulin manufacturing facility in Germany
19 November 2026 -

Professional services company Jacobs (NYSE:J) said on Thursday that it has been appointed by French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) as the engineering, procurement and construction management (EPCM) partner for a new insulin manufacturing facility in Frankfurt, Germany, aimed at modernising production and strengthening supply reliability.

Located alongside Sanofi's existing insulin manufacturing campus, the facility will support the production of multiple insulin products and incorporate advanced manufacturing technologies.

Jacobs will provide integrated EPCM services covering design, procurement, construction management and commissioning, deploying multidisciplinary teams to oversee the project through startup. The development will leverage existing site infrastructure and advanced manufacturing systems to support efficient operations.

Login
Username:

Password: